Sortis and transaminases increased Patient Reports February 13, 2012
Sortis Side Effects Report #4776557-8
Sortis side effect was reported by a Physician from SWITZERLAND on Sept 02, 2005. Female patient, 55 years of age, was diagnosed with type iia hyperlipidaemia and was treated with Sortis. After drug was administered, patient experienced the following side effects: pigment nephropathy, transaminases increased. Sortis dosage: 80 MG (1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Sortis Side Effects Report #5577500-4
Sortis side effect was reported by a Physician from GERMANY on Dec 18, 2007. Male patient, 51 years of age, was diagnosed with type iia hyperlipidaemia and was treated with Sortis. After drug was administered, patient experienced the following side effects: blood triglycerides increased, pancreatitis, transaminases increased. Sortis dosage: unknown. During the same period patient was treated with EZETROL, NICOTINIC ACID. Patient was hospitalized. Patient recovered.
Sortis Side Effects Report #4868780-9
Sortis side effect was reported by a Physician from GERMANY on Dec 16, 2005. Male patient, 62 years of age, weighting 172.0 lb, was diagnosed with myocardial infarction and was treated with Sortis. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, raynaud's phenomenon, transaminases increased. Sortis dosage: 40 MG (1 IN 1 D), ORAL. During the same period patient was treated with METOPROLOL SUCCINATE, CORVATON, LORZAAR, PLAVIX, ACETYLSALICYLIC ACID SRT, RAMIPRIL. Patient recovered.
Sortis Side Effects Report #4769024-9
Sortis side effect was reported by a Physician from SWITZERLAND on Sept 01, 2005. Female patient, 55 years of age, was diagnosed with ill-defined disorder and was treated with Sortis. After drug was administered, patient experienced the following side effects: pigment nephropathy, transaminases increased. Sortis dosage: 80 MG, ORAL. Patient was hospitalized. Patient recovered.
Sortis Side Effects Report #4608872-2
Sortis side effect was reported by a Physician from on Mar 01, 2005. Male patient, 70 years of age, weighting 205.0 lb, was diagnosed with coronary artery disease
, hyperlipidaemia, prostate cancer
and was treated with Sortis. After drug was administered, patient experienced the following side effects: prostatic specific antigen increased, renal failure, rhabdomyolysis, transaminases increased. Sortis dosage: 40 MG (40 MG, 1 IN 1 D), ORAL MORE THAN ONE YEAR. During the same period patient was treated with CYPROTERONE ACETATE, EZETIMIBE, PHENPROCOUMON, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.Sortis Side Effects Report #5572145-4
Sortis side effect was reported by a Physician from ROMANIA on Dec 12, 2007. Female patient, weighting 169.8 lb, was diagnosed with cardiovascular event prophylaxis, dyslipidaemia, hypertension and was treated with Sortis. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, myalgia, rhabdomyolysis, transaminases increased. Sortis dosage: unknown. During the same period patient was treated with INDAPAMIDE, AMLODIPINE, PERINDOPRIL, DIOSMIN, ACETYLSALICYLIC ACID SRT, AUGMENTIN. Patient was hospitalized. Patient recovered.
Sortis and transaminases increased 